![Seth Harmon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seth Harmon
Finansdirektör/CFO på
VIRIDIAN THERAPEUTICS, INC.
Förmögenhet: 138 317 $ per 2026-05-31
Profil
Seth Harmon is currently Chief Financial & Accounting Officer at Viridian Therapeutics, Inc. since 2023.
Formerly, Mr. Harmon was Chief Financial Officer at BioNTech SE from 2020 to 2023 and Vice President-Finance at BioNTech US, Inc. from 2017 to 2020.
Mr. Harmon completed undergraduate studies at Bowdoin College and earned graduate degrees, including an MBA, from Northeastern University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-31 | 7 850 ( 0,01 % ) | 138 317 $ | 2026-05-31 |
Aktiva positioner av Seth Harmon
| Företag | Position | Start |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Finansdirektör/CFO | 2023-09-12 |
Tidigare kända positioner av Seth Harmon
| Företag | Position | Slut |
|---|---|---|
| BIONTECH SE | Finansdirektör/CFO | 2023-05-01 |
| NEON THERAPEUTICS, INC. | Företagsledare/Principal | 2020-05-01 |
Seth Harmons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
5
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNTech SE
 BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
BioNTech US, Inc.
 BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer | Health Technology |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
![\"G](\"https://www.zonebourse.com/images/ImagesTagged/GD/2026/google/Google__G__logo.svg\"){kind=logo}
Välj MarketScreener 
